mRNA vaccines against SARS-CoV-2: Advantages and caveats

M Echaide, L Chocarro de Erauso… - International Journal of …, 2023 - mdpi.com
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …

[HTML][HTML] Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic …

VM Ferreira, S Plein, TC Wong, Q Tao… - Journal of …, 2023 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic that has
affected nearly 600 million people to date across the world. While COVID-19 is primarily a …

[HTML][HTML] COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated …

K Faksova, D Walsh, Y Jiang, J Griffin, A Phillips… - Vaccine, 2024 - Elsevier
Abstract Background The Global COVID Vaccine Safety (GCoVS) Project, established in
2021 under the multinational Global Vaccine Data Network™(GVDN®), facilitates …

Association of COVID-19 infection with incident diabetes

Z Naveed, HAV García, S Wong, J Wilton… - JAMA Network …, 2023 - jamanetwork.com
Importance SARS-CoV-2 infection may lead to acute and chronic sequelae. Emerging
evidence suggests a higher risk of diabetes after infection, but population-based evidence is …

Sex‐specific differences in myocardial injury incidence after COVID‐19 mRNA‐1273 booster vaccination

N Buergin, P Lopez‐Ayala, JR Hirsiger… - European Journal of …, 2023 - Wiley Online Library
Aims To explore the incidence and potential mechanisms of oligosymptomatic myocardial
injury following COVID‐19 mRNA booster vaccination. Methods and results Hospital …

Comparative risks of potential adverse events following COVID-19 mRNA vaccination among older US adults

DA Harris, KN Hayes, AR Zullo, V Mor… - JAMA Network …, 2023 - jamanetwork.com
Importance Head-to-head safety comparisons of the mRNA vaccines for SARS-CoV-2 are
needed for decision making; however, current evidence generalizes poorly to older adults …

Myocarditis and pericarditis post-mRNA COVID-19 vaccination: insights from a pharmacovigilance perspective

A Alami, PJ Villeneuve, PJ Farrell, D Mattison… - Journal of Clinical …, 2023 - mdpi.com
Concerns remain regarding the rare cardiovascular adverse events, myocarditis and
pericarditis (myo/pericarditis), particularly in younger individuals following mRNA COVID-19 …

[PDF][PDF] Chocarro de Erauso

M Echaide - Bocanegra, A., Blanco, E., Kochan, G. and …, 2023 - academica-e.unavarra.es
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection has
constituted a determinant resource to control the COVID-19 pandemic. Since the beginning …

Recent advances in the lipid nanoparticle-mediated delivery of mRNA vaccines

K Swetha, NG Kotla, L Tunki, A Jayaraj, SK Bhargava… - Vaccines, 2023 - mdpi.com
Lipid nanoparticles (LNPs) have recently emerged as one of the most advanced
technologies for the highly efficient in vivo delivery of exogenous mRNA, particularly for …

Fulminant Myocarditis Temporally Associated with COVID-19 Vaccination

E Ammirati, N Conti, M Palazzini, M Rocchetti… - Current Cardiology …, 2024 - Springer
Abstract Purpose of Review Coronavirus disease-2019 (COVID-19) vaccines have been
related to rare cases of acute myocarditis, occurring between 1 in 10,000 and 1 in 100,000 …